SenzaGen AB
SSE:SENZA.ST
Overview | Financials
Company Name | SenzaGen AB |
Symbol | SENZA.ST |
Currency | SEK |
Price | 6.7 |
Market Cap | 161,234,830 |
Dividend Yield | 0% |
52-week-range | 6.08 - 13.1 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Peter Nahlstedt |
Website | https://senzagen.com |
An error occurred while fetching data.
About SenzaGen AB
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD